Integrated genomic analysis to identify druggable targets for pancreatic cancer

Integrated genomic analysis to identify druggable targets for pancreatic cancer

According to the National Comprehensive Cancer Network and the American Society of Clinical Oncology, the standard treatment for pancreatic cancer (PC) is gemcitabine and fluorouracil. Other chemotherapeutic agents have been widely combined. However, drug resistance remains a huge challenge, leading...

Full description

Bibliographic Details
Main Authors: Eko Mugiyanto, Wirawan Adikusuma, Lalu Muhammad Irham, Wan-Chen Huang, Wei-Chiao Chang, Chun-Nan Kuo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
genomic
pancreatic cancer
drug repurposing
fulvestrant
midostaurin
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.989077/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.989077/full

Similar Items